Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...
Sentinel lymph node biopsy has replaced traditional axillary dissection, minimizing lymphedema risk in breast cancer surgery. The procedure targets the first draining lymph nodes, reducing unnecessary ...
Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy (SLNB) is a low-risk procedure that can reduce the need for complete lymph node ...
Lymphedema risk varies significantly by cancer type and lymph node removal extent, necessitating personalized risk assessments. Misconceptions about lymphedema precautions, such as avoiding blood ...
Patients with advanced pathologic stage, a higher number of positive lymph nodes, and positive surgical margins had the highest risks of dying from prostate cancer. Lymph node positive (pN1) prostate ...
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival We retrospectively ...
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...
Cancer that starts in the lymph nodes is lymphoma. Cancer may also spread from other areas of the body to various lymph nodes, including the neck. Swollen lymph nodes are usually due to a cause other ...
TAMPA, Fla. (Oct. 22, 2025) — A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma patients who have a low risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results